<DOC>
	<DOCNO>NCT00000524</DOCNO>
	<brief_summary>To determine whether immunosuppressive treatment improve cardiac function patient biopsy-proven myocarditis .</brief_summary>
	<brief_title>Myocarditis Treatment Trial</brief_title>
	<detailed_description>BACKGROUND : Heart failure due myocarditis devastate illness . At time , immunosuppressive therapy associate considerable risk untoward side effect . Clinicians know whether , circumstance , form , hazardous treatment use critically ill patient . In addition , immunosuppressive therapy benefit , endomyocardial biopsy patient suspect myocarditis justified procedure . The trial also provide information concern side effect immuno-suppressive therapy patient . DESIGN NARRATIVE : Patients randomize two treatment arm consist conventional therapy alone congestive heart failure combine twenty-four week regimen immunosuppressive therapy . Immunosuppressive therapy consist prednisone either cyclosporine azathioprine . The primary outcome measure change leave ventricular ejection fraction twenty-eight week . Secondary endpoint include survival , failure therapy , requirement conventional therapy , assessment symptom , myocardial histology , arrhythmia . The study completion date list record obtain Query/View/Report ( QVR ) System .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Myocarditis</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<criteria>Men woman , 18 year age old , leave ventricular failure biopsydocumented myocarditis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>